All Stories

  1. Age, sex and disease-specific associations between resting heart rate and cardiovascular mortality in the UK BIOBANK
  2. Cardiovascular research highlights from the UK Biobank: opportunities and challenges
  3. Genome-wide analysis of left ventricular image-derived phenotypes
  4. European Association of Cardiovascular Imaging expert consensus paper: a comprehensive review of cardiovascular magnetic resonance normal values of cardiac chamber size and aortic root in adults and recommendations for grading severity
  5. Pulmonary blood volume index as a quantitative biomarker of haemodynamic congestion in hypertrophic cardiomyopathy
  6. Automated quality control in heart image segmentation
  7. Physical activity and left ventricular trabeculation in the UK Biobank community-based cohort study
  8. Left ventricular shape models show consistent association with cardiovascular risk factors
  9. Association between air pollution and cardiac structure
  10. Athlete’s Heart: Diagnostic Challenges and Future Perspectives
  11. Lifestyle advice and interventions for cardiovascular risk reduction: A systematic review of guidelines
  12. Link between lung function and heart health
  13. A strong handgrip is associated with healthy heart size and heart function
  14. Effects of​ hormone replacement therapy on the heart
  15. Broken bones in elderly and risk of ischaemic cardiovascular events
  16. Diagnosing coronary artery disease using functional imaging tests after abnormal cardiac CT
  17. Calcium and Vitamin D Supplementation Are Not Associated With Risk of Incident Ischemic Cardiac Events or Death: Findings From the UK Biobank Cohort
  18. New insights into the mechanisms of chest pain in apical hypertrophic cardiomyopathy
  19. Diagnosis and Prognosis in Sudden Cardiac Arrest Survivors Without Coronary Artery DiseaseCLINICAL PERSPECTIVE
  20. Myocardial deformation assessment using cardiovascular magnetic resonance-feature tracking technique
  21. High BMI and blood pressure create a heavy heart
  22. Protocol and quality assurance for carotid imaging in 100,000 participants of UK Biobank: development and assessment
  23. Excessive Trabeculations and Prognosis
  24. Hypertrabeculated Left Ventricular Myocardium in Relationship to Myocardial Function and Fibrosis: The Multi-Ethnic Study of Atherosclerosis
  25. Pericardial, But Not Hepatic, Fat by CT Is Associated With CV Outcomes and Structure
  26. Fully-automated left ventricular mass and volume MRI analysis in the UK Biobank population cohort
  27. LV Noncompaction Cardiomyopathy or Just a Lot of Trabeculations?
  28. Key Questions Relating to Left Ventricular Noncompaction Cardiomyopathy: Is the Emperor Still Wearing Any Clothes?
  29. Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document
  30. Normal ranges for heart structure and function for heart MRI scans derived from UK Biobank data
  31. Community delivery of semiautomated fractal analysis tool in cardiac mr for trabecular phenotyping
  32. Left Atrial Structure in Relationship to Age, Sex, Ethnicity, and Cardiovascular Risk FactorsCLINICAL PERSPECTIVE
  33. The global cardiovascular magnetic resonance registry (GCMR) of the society for cardiovascular magnetic resonance (SCMR): its goals, rationale, data infrastructure, and current developments
  34. Cost-effectiveness of the polypill versus risk assessment for prevention of heart attackes
  35. Le risque d’événements cardiovasculaires est augmenté chez les hommes aux antécédents de fracture par fragilité osseuse : résultats de la cohorte UK Biobank
  36. Left Ventricular Noncompaction, or Is It? ∗
  37. Evaluation of splenic switch off in a tertiary imaging centre: validation and assessment of utility
  38. Cardiac Remodeling
  39. Cardiovascular Risk Assessment
  40. Systematic review of cost-effectiveness of strategies detecting suspected coronary artery disease
  41. 84 Cardiovascular Risk Reduction Using Contemporary Guideline Recommendations: Outcomes of the Heart Attack Prevention Programme for You (Happy) London Study: Abstract 84 Table 1
  42. Coronary atherosclerotic plaque burden and composition by CT angiography in Caucasian and South Asian patients with stable chest pain
  43. EACVI appropriateness criteria for the use of cardiovascular imaging in heart failure derived from European National Imaging Societies voting
  44. Comparison of Cartesian and Non-Cartesian Real-Time MRI Sequences at 1.5T to Assess Velar Motion and Velopharyngeal Closure during Speech
  45. Lung Deflation and Cardiovascular Structure and Function in Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial
  46. A review of heart chamber segmentation for structural and functional analysis using cardiac magnetic resonance imaging
  47. Automated Quality Assessment of Cardiac MR Images Using Convolutional Neural Networks
  48. Towards the Semantic Enrichment of Free-Text Annotation of Image Quality Assessment for UK Biobank Cardiac Cine MRI Scans
  49. Heart MRI protocol used in UK Biobank's imaging study of 100,000 people
  50. Cardiovascular magnetic resonance imaging of myocardial oedema following acute myocardial infarction: Is whole heart coverage necessary?
  51. Cost-minimization analysis of three decision strategies for cardiac revascularization: results of the “suspected CAD” cohort of the european cardiovascular magnetic resonance registry
  52. Fractal Analysis of Myocardial Trabeculations in 2547 Study Participants: Multi-Ethnic Study of Atherosclerosis
  53. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies
  54. P21 The applicability of current cardiovascular risk scores and cardiovascular surrogates in chronic obstructive pulmonary disease: A case-control study
  55. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies
  56. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
  57. Fractal frontiers in cardiovascular magnetic resonance: towards clinical implementation
  58. Splenic Switch-off: A Tool to Assess Stress Adequacy in Adenosine Perfusion Cardiac MR Imaging
  59. Extracellular volume quantification in isolated hypertension - changes at the detectable limits?
  60. Left Ventricular Noncompaction
  61. 2015 Update on Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR Registry
  62. Visceral adiposity and left ventricular remodeling: The Multi-Ethnic Study of Atherosclerosis
  63. LB01.07
  64. Different Imaging Strategies in Patients With Possible Basilar Artery Occlusion
  65. EuroEcho-Imaging 2014: highlights
  66. The Optimal Imaging Strategy for Patients With Stable Chest Pain
  67. The multi-modality cardiac imaging approach to the Athlete's heart: an expert consensus of the European Association of Cardiovascular Imaging
  68. Multimodality imaging in hypertrophic cardiomyopathy
  69. The science of clinical practice: disease diagnosis or patient prognosis? Evidence about “what is likely to happen” should shape clinical practice
  70. A comparison of cardiac motion analysis software packages: application to left ventricular deformation analysis in hypertensive patients
  71. Assessment of cardiovascular magnetic resonance aortic stiffness in patients with increased cardiovascular risk: role of traditional risk factors and lung hyperinflation
  72. Cardiovascular magnetic resonance feature tracking in patients with acute myocarditis and normal ejection fraction: potential for improved diagnosis and prognosis
  73. Excessive left ventricular trabeculation does not promote cardiac dysfunction in asymptomatic middle aged and older individuals with preserved cardiac function: an analysis from the Multi-Ethnic Study of Atherosclerosis
  74. Myocardial viability
  75. Quantification of the relationship between two cardiac magnetic resonance techniques: fast gradient echo and steady-state free precession for determination of left atrial volumes
  76. Splenic switch-off, a potential novel marker of lack of adenosine response: prevalence and measurement reproducibility
  77. Splenic switch-off, a potential novel marker of lack of adenosine response: relationship to heart rate response and demographic factors
  78. The impact of chronic obstructive pulmonary disease (COPD) and its associated lung hyperinflation on cardiac structure and function
  79. Obese Subjects Show Sex-Specific Differences in Right Ventricular Hypertrophy
  80. The Relationship of Left Ventricular Trabeculation to Ventricular Function and Structure Over a 9.5-Year Follow-Up
  81. Myocardial tissue phase mapping reveals impaired myocardial tissue velocities in obesity
  82. Diagnostic Performance and Comparative Cost-Effectiveness of Non-invasive Imaging Tests in Patients Presenting with Chronic Stable Chest Pain with Suspected Coronary Artery Disease: A Systematic Overview
  83. “3D Fusion” Echocardiography Improves 3D Left Ventricular Assessment: Comparison with 2D Contrast Echocardiography
  84. Update of the European Association of Cardiovascular Imaging (EACVI) Core Syllabus for the European Cardiovascular Magnetic Resonance Certification Exam
  85. EuroEcho-Imaging 2013: highlights
  86. Reporting standards in cardiac MRI, CT, and SPECT diagnostic accuracy studies: analysis of the impact of STARD criteria
  87. CMR in Heart Failure: Current and Emerging Clinical Applications
  88. Comparative cost-effectiveness analyses of cardiovascular magnetic resonance and coronary angiography combined with fractional flow reserve for the diagnosis of coronary artery disease
  89. Linking left ventricular function and mural architecture: what does the clinician need to know?
  90. Quantitative Computed Tomographic Coronary Angiography: Does It Predict Functionally Significant Coronary Stenoses?
  91. Reproducibility of arterial stiffness and wave reflections in chronic obstructive pulmonary disease: The contribution of lung hyperinflation and a comparison of techniques
  92. Effect of atrial fibrillation ablation on myocardial function: insights from cardiac magnetic resonance feature tracking analysis
  93. Concentric left ventricular remodeling and aortic stiffness: A comparison of obesity and hypertension
  94. CMR and LV Noncompaction∗
  95. Diagnostic performance of hyperaemic myocardial blood flow index obtained by dynamic computed tomography: does it predict functionally significant coronary lesions?
  96. Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: A 2-center study
  97. Use of Cardiac Magnetic Resonance and Echocardiography in Population-Based Studies: Why, Where, and When?
  98. Diagnostic Accuracy of Cardiac Magnetic Resonance Imaging in the Detection and Characterization of Left Atrial Catheter Ablation Lesions: A Multicenter Experience
  99. Rationale, challenges and approaches to image hearts of 100,000 people in UK Biobank
  100. European cardiovascular magnetic resonance (EuroCMR) registry – multi national results from 57 centers in 15 countries
  101. Global and regional left ventricular myocardial deformation measures by magnetic resonance feature tracking in healthy volunteers: comparison with tagging and relevance of gender
  102. Raised troponin in COPD: clinical implications and possible mechanisms
  103. Is there a role for stress CMR in stable chest pain with >60% predicted risk of coronary artery disease?
  104. Gender-specific differences in left ventricular remodelling in obesity: insights from cardiovascular magnetic resonance imaging
  105. Acute exacerbation of COPD is associated with fourfold elevation of cardiac troponin T
  106. ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 appropriate use criteria for peripheral vascular ultrasound and physiological testing part I: Arterial ultrasound and physiological testing
  107. ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 Appropriate Use Criteria for Peripheral Vascular Ultrasound and Physiological Testing Part I: Arterial Ultrasound and Physiological Testing
  108. Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease?
  109. Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts
  110. 050 Automated analysis of atrial delayed enhancement cardiac MRI correlates with voltage, AF recurrence post-ablation, and high stroke risk
  111. Magnetic resonance imaging pre and post pulmonary vein isolation for atrial fibrillation: diagnostic accuracy to detect and characterize ablation lesions
  112. Cardiovascular changes in patients with adult-onset growth hormone deficiency assessed by CMR
  113. Cardiovascular changes in patients with acromegaly assessed by CMR
  114. CMR right ventricular strain assessment using feature tracking cine images: agreement with echocardiography
  115. Cardiac magnetic resonance perfusion imaging using a single intravenous line
  116. Coronary Artery Stents
  117. Gender specific differences in left ventricular remodelling in obesity may explain differences in obesity related mortality
  118. The natural time course of myocardial oedema in the 12 months post ST-elevation MI in patients treated with primary angioplasty
  119. Late Gadolinium Enhancement CMR Predicts Adverse Cardiovascular Outcomes and Mortality in Patients With Coronary Artery Disease: Systematic Review and Meta-Analysis
  120. The Authors' reply
  121. Cardiovascular MRI in clinical trials: expanded applications through novel surrogate endpoints
  122. 108 4D-flow CMR demonstrates the regional distribution of aortic flow disturbance in Marfan syndrome
  123. With the “Universal Definition,” Measurement of Creatine Kinase-Myocardial Band Rather Than Troponin Allows More Accurate Diagnosis of Periprocedural Necrosis and Infarction After Coronary Intervention
  124. CMR real-time, free-breathing, phase contrast flow quantification: a novel approach to assess ventricular coupling in constrictive pericarditis
  125. Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study
  126. Myocardial Injury following Coronary Artery Surgery versus Angioplasty (MICASA): a randomised trial using biochemical markers and cardiac magnetic resonance imaging
  127. High-Resolution 3D Unenhanced ECG-Gated Respiratory-Navigated MR Angiography of the Renal Arteries: Comparison With Contrast-Enhanced MR Angiography
  128. Acute myocarditis presenting as acute coronary syndrome: role of early cardiac magnetic resonance in its diagnosis
  129. High-resolution 3D non-contrast-enhanced, ECG-gated, multi-step MR angiography of the lower extremities: Comparison with contrast-enhanced MR angiography
  130. Ventricular hypertrophy and cavity dilatation in relation to body mass index in women with uncomplicated obesity
  131. Reply
  132. Letter by Yilmaz et al Regarding Article, "Analysis of Dystrophin Deletion Mutations Predicts Age of Cardiomyopathy Onset in Becker Muscular Dystrophy"
  133. Managing Superior Vena Cava Syndrome as a Complication of Pacemaker Implantation: A Pooled Analysis of Clinical Practice
  134. Local Transient Myocardial Liposomal Gene Transfer of Inducible Nitric Oxide Synthase Does Not Aggravate Myocardial Function and Fibrosis and Leads to Moderate Neovascularization in Chronic Myocardial Ischemia in Pigs
  135. MRI after implantation of a novel femoral closure device following intra-arterial catheterisation: implications for subsequent contrast-enhanced MR angiography
  136. 31P cardiac magnetic resonance spectroscopy during leg exercise at 3 Tesla
  137. Beneficial Cardiovascular Effects of Bariatric Surgical and Dietary Weight Loss in Obesity
  138. Usefulness of MRI to Differentiate Between Temporary and Long-Term Coronary Artery Occlusion in a Minimally Invasive Model of Experimental Myocardial Infarction
  139. Area at Risk and Viability after Myocardial Ischemia and Reperfusion Can Be Determined by Contrast-Enhanced Cardiac Magnetic Resonance Imaging
  140. Determinants of left ventricular mass in obesity; a cardiovascular magnetic resonance study
  141. Early changes in arterial structure and function following statin initiation: Quantification by magnetic resonance imaging
  142. First experiences with contrast-enhanced first-pass MR perfusion imaging in patients with primary, benign cardiac masses and tumour-like lesions
  143. Redefining cardiomyopathies: the role of cardiovascular magnetic resonance imaging
  144. Assessment of Left Atrial Volumes at 1.5 Tesla and 3 Tesla Using FLASH and SSFP Cine Imaging
  145. Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging
  146. Dynamic Contrast-Enhanced MRI Before and After Transcatheter Occlusion of Patent Foramen Ovale
  147. Effects of steady state free precession parameters on cardiac mass, function, and volumes
  148. Cardiac Cine MR-Imaging at 3T: FLASH vs SSFP
  149. Time-Resolved Contrast-Enhanced MR Angiography of the Thorax in Adults with Congenital Heart Disease
  150. Functional and Structural Vascular Remodeling in Elite Rowers Assessed by Cardiovascular Magnetic Resonance
  151. Myocardial Tissue Phase Mapping with Cine Phase-Contrast MR Imaging: Regional Wall Motion Analysis in Healthy Volunteers
  152. Reply
  153. Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO): Planning and Follow-Up Using Contrast-Enhanced MRI
  154. Determination of cardiac volumes and mass with FLASH and SSFP cine sequences at 1.5 vs. 3 Tesla: A validation study
  155. Detailed analysis of myocardial motion in volunteers and patients using high-temporal-resolution MR tissue phase mapping
  156. Sex-specific characteristics of cardiac function, geometry, and mass in young adult elite athletes
  157. Thrombus Detection in the Left Atrial Appendage Using Contrast-Enhanced MRI: A Pilot Study
  158. Resting Myocardial Blood Flow Is Impaired in Hibernating Myocardium: A Magnetic Resonance Study of Quantitative Perfusion Assessment
  159. Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations
  160. Normal Human Left and Right Ventricular and Left Atrial Dimensions Using Steady State Free Precession Magnetic Resonance Imaging
  161. The morphological spectrum of ventricular noncompaction
  162. Left Ventricular Non-Compaction
  163. Differentiation of Athlete's Heart from Pathological Forms of Cardiac Hypertrophy by Means of Geometric Indices Derived from Cardiovascular Magnetic Resonance
  164. Troponin Elevation After Percutaneous Coronary Intervention Directly Represents the Extent of Irreversible Myocardial Injury: Insights From Cardiovascular Magnetic Resonance Imaging
  165. Relationship of irreversible myocardial injury to troponin I and creatine kinase-MB elevation after coronary artery bypass surgery: Insights from cardiovascular magnetic resonance imaging
  166. Diagnosis of Patent Foramen Ovale Using Contrast-Enhanced Dynamic MRI: A Pilot Study
  167. Quantification of resting myocardial blood flow in a pig model of acute ischemia based on first-pass MRI
  168. Global impairment of brachial, carotid, and aortic vascular function in young smokers
  169. Value of Delayed-Enhancement Cardiovascular Magnetic Resonance Imaging in Predicting Myocardial Viability After Surgical Revascularization
  170. Kardio-MRT
  171. Noonan-Syndrom mit der ungew�hnlichen Kombination von hypertropher Kardiomyopathie, konnatal bikuspider Aortenklappe und Aortenisthmusstenose mit hypoplastischem Aortenbogen
  172. 855-1 Effects of off-pump versus on-pump coronary surgery on early and late postoperative left ventricular function: A randomized trial using cardiovascular magnetic resonance imaging
  173. Effects of Off-Pump Versus On-Pump Coronary Surgery on Reversible and Irreversible Myocardial Injury: A Randomized Trial Using Cardiovascular Magnetic Resonance Imaging and Biochemical Markers
  174. Accuracy of Quantitative MR Vessel Wall Imaging Applying a Semi?Automated Gradient Detection Algorithm?A Validation Study
  175. Anteroseptal or Apical Myocardial Infarction: A Controversy Addressed Using Delayed Enhancement Cardiovascular Magnetic Resonance Imaging #
  176. Influence of Contrast Agent Dose and Image Acquisition Timing on the Quantitative Determination of Nonviable Myocardial Tissue Using Delayed Contrast?Enhanced Magnetic Resonance Imaging
  177. Visualization of the Ruptured Plaque by Magnetic Resonance Imaging
  178. Bestimmung der myokardialen Perfusionsreserve bei KHK-Patienten mit der kontrastmittelverstärkten MRT: Ein Vergleich zwischen semiquantitativer und quantitativer Auswertung
  179. MR-Perfusionsbildgebung des Herzens mit TrueFISP